CoChat

Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRα

Lehrke, Michael, Lebherz, Corinna, Millington, Segan C., Guan, Hong-Ping, Millar, John, Rader, Daniel J., Wilson, James M., Lazar, Mitchell A. · 2005 · Cell Metabolism
Cited by 45

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2005.04.005

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 46

  1. Barish, 2004, PPARs and LXRs: atherosclerosis goes nuclear, Trends Endocrinol. Metab., 15, 158, 10.1016/j.tem.2004.03.003 · DOI
  2. Baroukh, 2004, Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice, Arterioscler. Thromb. Vasc. Biol., 24, 1297, 10.1161/01.ATV.0000130463.68272.1d · DOI · Paper page
  3. Chiang, 2001, Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha), Gene, 262, 257, 10.1016/S0378-1119(00)00518-7 · DOI · Paper page
  4. Chisholm, 2003, The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse, J. Lipid Res., 44, 2039, 10.1194/jlr.M300135-JLR200 · DOI · Paper page
  5. DeBose-Boyd, 2001, Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands, Proc. Natl. Acad. Sci. USA, 98, 1477, 10.1073/pnas.98.4.1477 · DOI · Paper page
  6. Deeb, 1996, Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity, Hum. Mutat., 8, 319, 10.1002/(SICI)1098-1004(1996)8:4<319::AID-HUMU4>3.0.CO;2-2 · DOI
  7. Durrington, 2003, Dyslipidaemia, Lancet, 362, 717, 10.1016/S0140-6736(03)14234-1 · DOI · Paper page
  8. Foster, 2004, The role of the carnitine system in human metabolism, Ann. N Y Acad. Sci., 1033, 1, 10.1196/annals.1320.001 · DOI · Paper page
  9. Gao, 2002, Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy, Proc. Natl. Acad. Sci. USA, 99, 11854, 10.1073/pnas.182412299 · DOI · Paper page
  10. Goldberg, 1990, Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV, J. Biol. Chem., 265, 4266, 10.1016/S0021-9258(19)39557-2 · DOI · Paper page
  11. Grefhorst, 2002, Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles, J. Biol. Chem., 277, 34182, 10.1074/jbc.M204887200 · DOI · Paper page
  12. Guan, 2005, Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes, Genes Dev., 19, 453, 10.1101/gad.1263305 · DOI · Paper page
  13. Gupta, 2002, LXR alpha is the dominant regulator of CYP7A1 transcription, Biochem. Biophys. Res. Commun., 293, 338, 10.1016/S0006-291X(02)00229-2 · DOI
  14. Horton, 1999, Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL, J. Clin. Invest., 103, 1067, 10.1172/JCI6246 · DOI · Paper page
  15. Horton, 2003, Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes, Proc. Natl. Acad. Sci. USA, 100, 12027, 10.1073/pnas.1534923100 · DOI · Paper page
  16. Hu, 2000, Transcriptional repression by nuclear hormone receptors, Trends Endocrinol. Metab., 11, 6, 10.1016/S1043-2760(99)00215-5 · DOI · Paper page
  17. Hu, 2003, Liver x receptors interact with corepressors to regulate gene expression, Mol. Endocrinol., 17, 1019, 10.1210/me.2002-0399 · DOI · Paper page
  18. Ishibashi, 1993, Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery, J. Clin. Invest., 92, 883, 10.1172/JCI116663 · DOI · Paper page
  19. Jakel, 2004, The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c, J. Biol. Chem., 279, 45462, 10.1074/jbc.M404744200 · DOI · Paper page
  20. Janowski, 1996, An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha, Nature, 383, 728, 10.1038/383728a0 · DOI · Paper page
  21. Joseph, 2002, Synthetic LXR ligand inhibits the development of atherosclerosis in mice, Proc. Natl. Acad. Sci. USA, 99, 7604, 10.1073/pnas.112059299 · DOI · Paper page
  22. Lebherz, 2004, Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia, J. Gene Med., 6, 663, 10.1002/jgm.554 · DOI · Paper page
  23. Levin, 2005, Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists, Arterioscler. Thromb. Vasc. Biol., 25, 135, 10.1161/01.ATV.0000150044.84012.68 · DOI · Paper page
  24. Levine, 1995, Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms, N. Engl. J. Med., 332, 512, 10.1056/NEJM199502233320807 · DOI · Paper page
  25. Liang, 2004, Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists, Mol. Endocrinol., 18, 2000, 10.1210/me.2003-0477 · DOI
  26. Lin, 2005, Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP, Cell, 120, 261, 10.1016/j.cell.2004.11.043 · DOI · Paper page
  27. Mak, 2002, Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta, J. Biol. Chem., 277, 31900, 10.1074/jbc.M202993200 · DOI · Paper page
  28. Medh, 2000, Lipoprotein lipase- and hepatic triglyceride lipase-promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism, J. Lipid Res., 41, 1858, 10.1016/S0022-2275(20)31980-5 · DOI · Paper page
  29. Merkel, M., Loeffler, B., Kluger, M., Fabig, N., Geppert, G., Pennacchio, L.A., Laatsch, A., and Heeren, J. (2005). Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase. J. Biol. Chem. Published online March 17, 2005. 10.1074/jbc.M411412200. · DOI · Paper page
  30. Millatt, 2003, Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis, Biochim. Biophys. Acta, 1631, 107, 10.1016/S1388-1981(02)00366-9 · DOI
  31. Ordovas, 2004, Nutritional genomics, Annu. Rev. Genomics Hum. Genet., 5, 71, 10.1146/annurev.genom.5.061903.180008 · DOI · Paper page
  32. Pastinen, 2004, A survey of genetic and epigenetic variation affecting human gene expression, Physiol. Genomics, 16, 184, 10.1152/physiolgenomics.00163.2003 · DOI · Paper page
  33. Peet, 1998, The LXRs: a new class of oxysterol receptors, Curr. Opin. Genet. Dev., 8, 571, 10.1016/S0959-437X(98)80013-0 · DOI · Paper page
  34. Peet, 1998, Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha, Cell, 93, 693, 10.1016/S0092-8674(00)81432-4 · DOI · Paper page
  35. Rader, 2003, Monogenic hypercholesterolemia: new insights in pathogenesis and treatment, J. Clin. Invest., 111, 1795, 10.1172/JCI200318925 · DOI · Paper page
  36. Repa, 2000, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev., 14, 2819, 10.1101/gad.844900 · DOI · Paper page
  37. Repa, 2002, Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta, J. Biol. Chem., 277, 18793, 10.1074/jbc.M109927200 · DOI · Paper page
  38. Schultz, 2000, Role of LXRs in control of lipogenesis, Genes Dev., 14, 2831, 10.1101/gad.850400 · DOI · Paper page
  39. Schuster, 2002, Accumulation of foam cells in liver X receptor-deficient mice, Circulation, 106, 1147, 10.1161/01.CIR.0000026802.79202.96 · DOI · Paper page
  40. Spady, 1998, Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced, J. Biol. Chem., 273, 126, 10.1074/jbc.273.1.126 · DOI
  41. Steffensen, 2004, Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals, J. Mol. Endocrinol., 33, 609, 10.1677/jme.1.01508 · DOI · Paper page
  42. Tangirala, 2002, Identification of macrophage liver X receptors as inhibitors of atherosclerosis, Proc. Natl. Acad. Sci. USA, 99, 11896, 10.1073/pnas.182199799 · DOI · Paper page
  43. Terasaka, 2003, T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice, FEBS Lett., 536, 6, 10.1016/S0014-5793(02)03578-0 · DOI · Paper page
  44. Tontonoz, 2003, Liver X receptor signaling pathways in cardiovascular disease, Mol. Endocrinol., 17, 985, 10.1210/me.2003-0061 · DOI · Paper page
  45. Wagner, 2003, Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression, Mol. Cell. Biol., 23, 5780, 10.1128/MCB.23.16.5780-5789.2003 · DOI · Paper page
  46. Willy, 1995, LXR, a nuclear receptor that defines a distinct retinoid response pathway, Genes Dev., 9, 1033, 10.1101/gad.9.9.1033 · DOI · Paper page

Cited by

Metadata

Authors
Lehrke, M., Lebherz, C., Millington, S. C., Guan, H.-P., Millar, J., Rader, D. J., Wilson, J. M., & Lazar, M. A.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2005-05
Volume
1
Issue
5
Pages
297-308
ISSN
1550-4131
Cited by
45
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.